http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102007014286-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_239decbdfaad7a4b81cd476c15901a28 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-27 |
| filingDate | 2007-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d31c8be66f2152fa8c2420e4617b6d51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ece84cad2319f1ba87b2056f7fec894f |
| publicationDate | 2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102007014286-A1 |
| titleOfInvention | Fluorine-substituted amphetamines and amphetamine derivatives and their use |
| abstract | Described are fluorine-substituted amphetamines or amphetamine derivatives of the formula (I), wherein at least one of R 1 or R 2 is other than H and Ph is a phenyl ring substituted with fluorine at at least one position, or R 1 and R 2 are each independently H or H, and Ph is a phenyl ring which is at least substituted at three positions with fluorine, or the radicals R1 and R2 are independently H or different from H and Ph is a phenyl ring which is substituted at least at one position with fluorine and at least one further position having H different substituents. In addition, the use of fluorine-substituted amphetamines or amphetamine derivatives as medicaments, in particular for the treatment of neurological diseases, their consequences and / or for the treatment of side effects of a therapy of neurological diseases and a pharmaceutical composition comprising as active ingredient at least one fluorine-substituted amphetamine or an amphetamine derivative, is described. |
| priorityDate | 2007-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.